Choose Heart Treatments Wisely with Metro Hospitals’ Second Opinion

Hospital Group launches ‘HeartWise Second Opinion’ Program to narrow down to Just Right

Noida/ New Delhi: Heart disease is a mind baffling health condition. As specialists of differing treatment options stick to their guns and fiercely guard their own turfs, most of the times patients find themselves at their wit’s end. They are like what to choose bypass surgery or angioplasty, whether chest pain is being caused by gas or relates to some heart condition- they have no one to lean on for right guidance. To create ‘Ease of Choosing’ ecosystem in cardiac domain, Metro hospitals have launched ‘HeartWise Second Opinion’ program.

Metro hospitals will adopt ‘Heart Team’ approach to help patients choose the kind of treatment wisely. Talking to media, Dr. Vinay Kumar Bahal (ex-HOD, Cardiology, AIIMS New Delhi) and Dr. Sameer Gupta (Senior Interventional Cardiologist & Group Head—Cardiac Cath Lab) spoke at length on the importance of second opinion in choosing right option. Dr Bahal warned of finding the answers on whatsapp or on internet. Talking to Medicare News, Dr Bahal said, ‘Such dubious sources might lead them to wrong decision and bad outcome. We see patients who come after having 4 or 5 opinions, yet are confused about the way forward. ‘Heart Team’ approach is the best foot forward for heart treatment.’

Dr Sameer Gupta said, ‘ As cardiac disease has assumed epidemic proportions, our program will go a long way in handholding confused patients to just right kind of treatment. We felt that such program is the need of the hour. Our HeartWise Second Opinion program is a clinician-led program designed to help heart patients choose the most appropriate treatment pathway—be it bypass surgery, stenting, or optimized medical therapy.

Both experts who would steer the novel program said nearly 30% of patients arrive uncertain about “what to do next” after visiting multiple hospitals and specialists. HeartWise Second Opinion addresses this decisional conflict with a structured, guideline-concordant review.

How the program works

  • Comprehensive case review: Senior interventional cardiologists evaluate recent angiography, echocardiography, and prior medical records, along with a detailed clinical history.
  • Only-if-needed testing: If any additional test is required to clarify anatomy or risk—such as functional assessment—it is advised judiciously.
  • Standards-based recommendation: Final advice aligns with internationally accepted clinical guidelines and is individualized to age, coronary anatomy, available facilities, and co-morbid conditions (e.g., diabetes, kidney disease).
  • Patient-first communication: The outcome is a clear, written treatment plan explained in plain language to the patient and famil

Dr. Sameer Gupta, Senior Interventional Cardiologist; Group Head—Cardiac Cath Lab; Director, Metro Group of Hospitals, said:
“We routinely see patients who have been advised different paths—stenting here, bypass there, medicines somewhere else. A systematic second opinion, grounded in evidence and the patient’s full clinical picture, brings clarity. Our goal is to match the right treatment to the right person at the right time—and to explain the ‘why’ behind that choice.”

Dr. Vinay Kumar Bahal added, “In over four decades of cardiology, one lesson stands out: outcomes improve when decisions are individualized. Age, vessel involvement, ventricle function, diabetes, kidney status—these details matter. HeartWise Second Opinion offers patients a calm, thorough review so that the final plan is not just scientifically sound, but also feasible and safe for that individual.”

Dr. Purshotam Lal, Chairman, Metro Group of Hospitals and a pioneer of interventional cardiology in India, added:
“Second opinions are a sign of responsible medicine. This program formalizes what good clinicians already do—listen carefully, analyze completely, and recommend transparently. Our commitment is simple: advice that is unbiased, patient-centric, and focused on long-term heart health.”

Who should consider HeartWise Second Opinion?

  • Patients advised bypass or stenting and wanting confirmation before proceeding
  • Individuals with multiple co-morbidities (e.g., diabetes, CKD) where risk–benefit trade-offs need careful balancing
  • Patients with borderline or conflicting recommendations from different centers
  • Families seeking a clear, consolidated plan after a recent angiography or hospitalization

How to enroll: Patients can book a HeartWise Second Opinion review at Metro Hospital, Noida or through Metro’s official website. Bring recent angiography (CD/films), echo reports, discharge summaries, and current medications.

 

Related Posts

A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

Healthy Heart is a Misnomer until underpinned by Regular Screening Bangaluru/ New Delhi: Of late, heart health has become kind of a veritable conundrum. We were never so unsure of…

Health Ministry Unveils Thalassemia Awareness Posters to Promote Early Screening

The aim is to encourage adolescents and antenatal women to undergo timely thalassemia screening New Delhi: The Ministry of Health and Family Welfare unveiled two awareness posters on thalassemia screening…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

Puducherry drugs inspector suspended after counterfeit medicine crackdown

Puducherry drugs inspector suspended after counterfeit medicine crackdown

Researchers discover a compound that can boost ageing muscle repair

Researchers discover a compound that can boost ageing muscle repair

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit